Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of KETAN SHAH as Chairman & Managing Director of the company w.e.f. August 12, 2025.
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has redesignated Mr. Ketan Shah from Whole Time Director to Chairman & Managing Director, effective August 12, 2025. The appointment is for a 3-year term ending August 11, 2028, subject to shareholder approval at the upcoming Annual General Meeting. Mr. Shah is a promoter of the company, aged 64, with 39 years of experience in the pharmaceutical industry, and is the uncle of existing Non-Executive Non-Independent Director Mr. Meet Shah. The company confirmed that Mr. Shah is not debarred from holding director office by any SEBI order or other authority.
This is a leadership elevation of an existing promoter-director rather than a fresh appointment, which signals continuity at the top for shareholders. The consolidation of Chairman and Managing Director roles in a single promoter hand may raise governance concerns for some investors, but it also brings unified strategic direction to the company.